Un-Monsanto to harness CRISPR to make un-GMOs

Biotech behemoth Monsanto was recently in the news for its merger with German pharmaceutical giant Bayer - a $66 billion deal which is reportedly the biggest yet this year and, if it goes through, may mean the end of the controversial Monsanto brand name. But if that massive merger is newsworthy, and it most certainly … Continue reading Un-Monsanto to harness CRISPR to make un-GMOs

Synthesizing Genomes and Weaponizing Gene Editing

Last month, a closed-door meeting at Harvard Medical School about synthesizing human DNA drew criticism for its secrecy. The 150 or so attendees at the meeting were told not to talk to the media, although a conference organizer said there was a misunderstanding about the reasons for this injunction. Still, it is understandable that the public is … Continue reading Synthesizing Genomes and Weaponizing Gene Editing